Skip to content
akaturk Academic measurement
  1. Ana Dal Sağlık Bilimleri Temel Alanı
  2. Yan Dal Tıbbi Biyoloji
Articles 13 YÖKSİS 13 · OpenAlex 0 Total citations 94 h-index 7 · OpenAlex Q1 articles 6 Scopus · WoS Q1 7 Co-authors 12 1 Turkish institutions

Citation impact

OpenAlex YÖKSİS articles matched in OpenAlex: 12 + YÖKSİS · co-author record: 1
h-index 7 Percentile in Türkiye: 67 #229 of 875 at their university by h-index
i10-index
5
Total citations
94
Top 40% in Türkiye
Per article
7.2
FWCI
0.86
1.00 = world average
World top 1%
0
World top 10%
1
How is this computed?

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included. 1 articles (10 citations) tagged with this academic’s YÖK author id in co-authors’ YÖKSİS records count only towards citations, h-index and i10; article counts, percentiles and rankings use their own YÖKSİS list.

Field ranking

YÖKSİS ?

Collaboration network

From the author lists of YÖKSİS publication records. Duplicate records of a work count once; institutions are co-authors’ current YÖKSİS affiliations.

Co-authors
12
With an akaturk profile
5
Turkish institutions
1
Co-authored works
%85

Academic co-authors 5

  1. İDRİS ER Araştırma Görevlisi · Karadeniz Teknik Üniversitesi 7
  2. TUBA DİNÇER Doçent · Karadeniz Teknik Üniversitesi 2
  3. ERSAN KALAY Profesör · Karadeniz Teknik Üniversitesi 1
  4. RAHŞAN EVREN MAZLUM Doçent · Recep Tayyip Erdoğan Üniversitesi same university 1
  5. SADETTİN BERKAY ŞARLI Araştırma Görevlisi · Karadeniz Teknik Üniversitesi 1

National collaboration 1 institutions

Within own university1 joint works · Recep Tayyip Erdoğan Üniversitesi

  1. Karadeniz Teknik Üniversitesi 9 works · 4 academics

Other co-authors (incl. international) 7

Zuhal Semiz 2CEREN SÜMEREbiha CanGulsum YetkinHelen SheldrakeMark SutherlandYusuf Ceylan

Authors without an akaturk profile (international researchers, retired or former academics, students, clinicians) are grouped by name spelling; short forms such as “Gulluce M.” join the single full name they match.

Indexes and citation percentiles

?
TR Index 2 articles
OpenAlex citation percentile
Top 1%0
Top 10%1
Avg · n 12 %60.4
Other counts

Scopus (SJR)

  • YÖKSİS rows 12

WoS (JCR)

  • YÖKSİS rows 12

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

13articles

Journals with publications

11 journals

Narrow down

Scopus (SJR)
WoS (JCR)
Q17 Q20 Q32 Q43
TR Index

Article list

  1. 2026 Investigating marine venoms: anticancer effects of Aurelia aurita on colorectal cancer cells by inhibiting migration, invasion, and proliferation Toxin Reviews DOI 10.1080/15569543.2026.2618199 YÖKSİS SJR Q3 JCR Q3 OpenAlex 6.3%
  2. 2026 Magnetic Fields in Cancer Therapy: Mechanistic Insights, Signaling Pathways, and Evidence from Clinical and In Vitro Studies Pharmaceutics DOI 10.3390/pharmaceutics18060742 YÖKSİS SJR Q1 JCR Q1 OpenAlex 53.6%
  3. 2025 Investigation of Notch Pathway Responsive Gene Expressions in Colon Cancer Rize Medical Journal DOI https://dergipark.org.tr/tr/pub/rizetip/article/1633027 YÖKSİS
  4. 2024 Overcoming Vemurafenib Resistance in Metastatic Melanoma: Targeting Integrins to Improve Treatment Efficacy International Journal of Medical Sciences DOI 10.3390/ijms25147946 YÖKSİS SJR Q2 JCR Q1 OpenAlex top 10% OpenAlex 91.0%
  5. 2024 The Correlation between BRAFV600E Expression and Integrin β3 in Melanoma Cells Proceedings of the Bulgarian Academy of Sciences DOI 10.7546/CRABS.2024.11.16 YÖKSİS SJR Q3 JCR Q4 OpenAlex 25.7%
  6. 2024 Hedgehog Pathway Is a Regulator of Stemness in HER2-Positive Trastuzumab-Resistant Breast Cancer International Journal of Molecular Sciences DOI 10.3390/ijms252212102 YÖKSİS SJR Q1 JCR Q1 OpenAlex 78.0%
  7. 2024 Targeting ITGβ3 to Overcome Trastuzumab Resistance through Epithelial–Mesenchymal Transition Regulation in HER2-Positive Breast Cancer International journal of Molecular Sciences DOI 10.3390/ijms25168640 YÖKSİS SJR Q1 JCR Q1 OpenAlex 86.2%
  8. 2024 Investigation of ITGB3 Heterogeneity to Overcome Trastuzumab Resistance in HER2-Positive Breast Cancer Biology DOI 10.3390/biology14010009 YÖKSİS SJR Q1 JCR Q1 OpenAlex 72.3%
  9. 2024 Integrin β3 Reprogramming Stemness in HER2-Positive Breast Cancer Cell Lines Biology DOI 10.3390/biology13060429 YÖKSİS SJR Q1 JCR Q1 OpenAlex 84.5%
  10. 2024 PAI1 Regulates Cell Morphology and Migration Markers in Trastuzumab-Resistant HER2-Positive Breast Cancer Cells Life DOI 10.3390/life14081040 YÖKSİS SJR Q1 JCR Q1 OpenAlex 75.4%
  11. 2024 Notch and Hedgehog Signalling Axis Drive Senescence in HER2-Positive Breast Cancer Resistant to Trastuzumab European Journal of Biology DOI 10.26650/EurJBiol.2024.1531120 YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 13.3%
  12. 2019 RIPK4 suppresses the TGF‐β1 signaling pathway in HaCaT cells Cell Biology International DOI 10.1002/cbin.11282 YÖKSİS SJR Q2 JCR Q3 OpenAlex 63.8%
  13. 2019 Keratin 14 is a novel interaction partner of keratinocyte differentiation regulator: receptor-interacting protein kinase 4 TURKISH JOURNAL OF BIOLOGY DOI 10.3906/biy-1904-37 YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 74.2%

← Back to academicians